Signatures of native-like glycosylation in RNA replicon-derived HIV-1 immunogens
Signatures of native-like glycosylation in RNA replicon-derived HIV-1 immunogens
RNA-based vaccines have emerged as a highly effective delivery platform. However, this approach eliminates the possibility for immunogen purification, common in manufacturing of recombinant immunogens. In HIV-1 vaccine design, this is of particular importance because non-native epitopes can compromise the desired immune response, and native immunogen assembly is important for presentation of glycan-based epitopes targeted by broadly neutralizing antibodies. Here, we investigate the assembly and glycosylation of the archetypal trimeric HIV-1 immunogen, BG505, in the soluble single-chain format (NFL.664) that bypasses the need of maturation by furin cleavage. We have investigated the presence of the trimer-associated mannose-patch as oligomannose-type structures at these N-linked glycosylation sites are indicative of native-like glycoprotein structure. Despite the presence of features of native-like glycosylation, both electron microscopy and glycopeptide analysis indicated the presence of a sub-population of non-native material. We also investigated the glycosylation of material derived from cell-types that likely produce immunogens near the site of intramuscular RNA injection. We show that replicon-transformed dendritic and muscle cell lines generate immunogens displaying similar oligomannose-type glycan content, whereas sites presenting complex-type glycosylation differed substantially in the levels of glycan processing. Overall, the control of the immunogen assembly by protein engineering is sufficient to drive native-like glycosylation at the majority of glycosylation sites independent of producer cells. Furthermore, we explored the engineering of RNA immunogens to improve glycan site occupancy. Controlling immunogen assembly at the nucleotide level offers a route to enhanced RNA-based immunogens.
400-413
Chawla, Himanshi
07b9e983-4c35-4314-999d-fe3222a6c03b
Willcox, Jacob T.
45cf5eda-aecf-46c2-b19d-60ce96c50a31
Hayes, Grace M.
bc6cb1b3-b8ef-438e-a16a-4bc039bda766
Silva, Murillo
aa05c6bd-991e-40f2-bebb-df491327256a
Lee, Wen-Hsin
a30e425f-7907-4f8c-b1e0-682dec238fae
Ozorowski, Gabriel
9d448a80-7310-4b30-ba44-ee8b18222a02
Butler, John
5132f0e2-f28d-412a-be9a-e97963b4c0ee
Mckay, Paul F.
563bfbd2-7285-4ad4-a500-a163f9101c36
Shattock, Robin J.
e102792f-de49-4b2c-bf53-ada9f5521603
Ward, Andrew B.
7b743524-72d4-448d-b645-11c55782b656
Irvine, Darrell J.
63f295b5-7d49-4c85-9e9b-4797cebf5f89
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9
11 March 2026
Chawla, Himanshi
07b9e983-4c35-4314-999d-fe3222a6c03b
Willcox, Jacob T.
45cf5eda-aecf-46c2-b19d-60ce96c50a31
Hayes, Grace M.
bc6cb1b3-b8ef-438e-a16a-4bc039bda766
Silva, Murillo
aa05c6bd-991e-40f2-bebb-df491327256a
Lee, Wen-Hsin
a30e425f-7907-4f8c-b1e0-682dec238fae
Ozorowski, Gabriel
9d448a80-7310-4b30-ba44-ee8b18222a02
Butler, John
5132f0e2-f28d-412a-be9a-e97963b4c0ee
Mckay, Paul F.
563bfbd2-7285-4ad4-a500-a163f9101c36
Shattock, Robin J.
e102792f-de49-4b2c-bf53-ada9f5521603
Ward, Andrew B.
7b743524-72d4-448d-b645-11c55782b656
Irvine, Darrell J.
63f295b5-7d49-4c85-9e9b-4797cebf5f89
Crispin, Max
cd980957-0943-4b89-b2b2-710f01f33bc9
Chawla, Himanshi, Willcox, Jacob T., Hayes, Grace M., Silva, Murillo, Lee, Wen-Hsin, Ozorowski, Gabriel, Butler, John, Mckay, Paul F., Shattock, Robin J., Ward, Andrew B., Irvine, Darrell J. and Crispin, Max
(2026)
Signatures of native-like glycosylation in RNA replicon-derived HIV-1 immunogens.
RSC Chemical Biology, 7 (3), .
(doi:10.1039/D5CB00165J).
Abstract
RNA-based vaccines have emerged as a highly effective delivery platform. However, this approach eliminates the possibility for immunogen purification, common in manufacturing of recombinant immunogens. In HIV-1 vaccine design, this is of particular importance because non-native epitopes can compromise the desired immune response, and native immunogen assembly is important for presentation of glycan-based epitopes targeted by broadly neutralizing antibodies. Here, we investigate the assembly and glycosylation of the archetypal trimeric HIV-1 immunogen, BG505, in the soluble single-chain format (NFL.664) that bypasses the need of maturation by furin cleavage. We have investigated the presence of the trimer-associated mannose-patch as oligomannose-type structures at these N-linked glycosylation sites are indicative of native-like glycoprotein structure. Despite the presence of features of native-like glycosylation, both electron microscopy and glycopeptide analysis indicated the presence of a sub-population of non-native material. We also investigated the glycosylation of material derived from cell-types that likely produce immunogens near the site of intramuscular RNA injection. We show that replicon-transformed dendritic and muscle cell lines generate immunogens displaying similar oligomannose-type glycan content, whereas sites presenting complex-type glycosylation differed substantially in the levels of glycan processing. Overall, the control of the immunogen assembly by protein engineering is sufficient to drive native-like glycosylation at the majority of glycosylation sites independent of producer cells. Furthermore, we explored the engineering of RNA immunogens to improve glycan site occupancy. Controlling immunogen assembly at the nucleotide level offers a route to enhanced RNA-based immunogens.
Text
d5cb00165j
- Version of Record
More information
Accepted/In Press date: 10 January 2026
e-pub ahead of print date: 12 January 2026
Published date: 11 March 2026
Identifiers
Local EPrints ID: 510975
URI: http://eprints.soton.ac.uk/id/eprint/510975
ISSN: 2633-0679
PURE UUID: 4886b1aa-4829-4a59-ac31-869cd311484f
Catalogue record
Date deposited: 28 Apr 2026 16:44
Last modified: 29 Apr 2026 01:55
Export record
Altmetrics
Contributors
Author:
Jacob T. Willcox
Author:
Murillo Silva
Author:
Wen-Hsin Lee
Author:
Gabriel Ozorowski
Author:
Paul F. Mckay
Author:
Robin J. Shattock
Author:
Andrew B. Ward
Author:
Darrell J. Irvine
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics